Health Trials

Relapsed or Metastatic Thymic Cancer

1

Review clinical trials related to Relapsed or Metastatic Thymic Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial

This study is a prospective, single arm phase II clinical trial ,aimed at exploring the efficacy and safety of the combination therapy of anti-PD-1 and VEGF bispecific antibody Ivonescimab combined with chemotherapy as first-line treatment of relapsed or metastatic thymic cancer.

Participants needed: 24
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Sun Yat-sen UniversityUpdated: Dec 27, 2024
Eligibility criteria

Untreated metastatic or recurrent inoperable thymic cancer patients at the initi... [+8]

Patients with thymoma component suspected by pathological diagnosis (only thymic... [+22]

Read more